瑞普生物: 第五届监事会第二十次（临时）会议决议公告

Group 1 - The company held its 20th (temporary) meeting of the 5th Supervisory Board on June 13, 2025, with all legal procedures followed for attendance and voting [1] - The Supervisory Board agreed to the transfer of equity in its subsidiary, Hunan Zhong'an Biological Pharmaceutical Co., Ltd., citing potential harm to the company and shareholders' interests [1] - The voting results for the equity transfer proposal were unanimous, with 3 votes in favor and no votes against or abstentions, pending approval from the shareholders' meeting [1] Group 2 - The Supervisory Board approved the provision of financial assistance to the controlling subsidiary, determining it would not significantly impact the company's daily operations and did not violate any regulations [2] - The decision regarding financial assistance also received unanimous support, with 3 votes in favor and no opposition or abstentions [2]